Search

everythinglearnresearchcommunity

for

Search:↓

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Ginkgo biloba polysaccharides may reduce inflammation and promote hair growth in mice with hair loss.

FGF21 can help reduce skin inflammation caused by C. acnes.

Frontal fibrosing alopecia on limbs shows permanent inflammatory hair loss, not typical scarring.

Bruguiera gymnorhiza leaf extracts show potential for developing anti-inflammatory drugs.

Inflammasome proteins can predict inflammation and outcomes in aneurysmal subarachnoid hemorrhage.

Light therapy reduces scalp inflammation, boosts hair regrowth with Minoxidil 2%.

Human placenta extract reduces inflammation and symptoms in atopic dermatitis.

Cardamonin reduces inflammation in gum tissue cells.

Improving diet may help manage sleep disorders.

Carthamus caeruleus root juice may reduce inflammation.

Rational design strategies are crucial for developing effective nanozymes for anti-inflammatory uses.

Bhamrung-Lohit may help with inflammation and oxidation.

Personalized medicine is important for treating skin disorders, with new treatments and connections to hormones and genetics being explored.

Beta-trace protein may help diagnose and predict treatment response in certain nerve disorders.

Botryococcus terribilis Ethanol Extract may reduce inflammation by changing gene expression in cells.

New natural hair loss treatments seem safer but need more research.

New therapies for rare skin diseases show promise but need more research.

Skin diseases like acne and psoriasis are linked to stress, gut health, and inflammation, with new treatments focusing on gut and mind-body approaches.

Fucoidan may help regrow hair and reduce inflammation in hair loss.

Monocyte-derived dendritic cells play a key role in UVB-induced skin sensitivity and inflammation.

Immune cells and cytokines significantly affect pathological scar development.

Calprotectin levels are higher in alopecia areata patients, indicating systemic inflammation.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Histone modification is key in treating chronic inflammatory skin diseases.

Gold nanoparticles show promise for treating inflammatory bowel disease by reducing inflammation and colon injury.

Long-COVID symptoms in children after MIS-C are similar across different COVID-19 variants, with older age being a key factor.

Higher inflammation markers are linked to more severe alopecia areata.

RCM and OCT are effective for diagnosing and monitoring hair-related skin diseases but lack standardized protocols and need more research.